Weinberg E, Shungu D L, Gadebusch H H
J Clin Microbiol. 1984 Feb;19(2):207-9. doi: 10.1128/jcm.19.2.207-209.1984.
The Antimicrobial Removal Device (ARD), BACTEC 16B medium, and Thiol broth were evaluated for their effectiveness in reducing the activity of imipenem (IPM), cefoxitin, moxalactam, and ceftazidime in blood samples. In addition, the capability of the ARD and Thiol broth to bind norfloxacin and the ARD to bind oxolinic and nalidixic acids in urine samples was investigated. At the highest concentrations of the drugs tested (32 micrograms/ml for the four beta-lactams and 256 micrograms/ml for the three quinolinecarboxylic acids), there was at least a 95% reduction in the in vitro activity of each of the antibacterial agents for treated versus untreated samples. Of the compounds tested in the ARD system, the organic acids were more completely removed than were the beta-lactams. The Thiol broth was more effective than the ARD and the BACTEC 16B medium in inactivating imipenem, but it had no effect on the antibacterial activity of norfloxacin.
对抗菌去除装置(ARD)、BACTEC 16B培养基和硫醇肉汤进行了评估,以确定它们在降低血液样本中亚胺培南(IPM)、头孢西丁、莫西沙星和头孢他啶活性方面的有效性。此外,还研究了ARD和硫醇肉汤结合尿液样本中诺氟沙星的能力以及ARD结合尿液样本中恶喹酸和萘啶酸的能力。在所测试药物的最高浓度下(四种β-内酰胺类药物为32微克/毫升,三种喹啉羧酸类药物为256微克/毫升),与未处理样本相比,每种抗菌剂的体外活性至少降低了95%。在ARD系统中测试的化合物中,有机酸比β-内酰胺类药物去除得更彻底。硫醇肉汤在使亚胺培南失活方面比ARD和BACTEC 16B培养基更有效,但对诺氟沙星的抗菌活性没有影响。